Follow the Avalyn Pharma Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.7bn. The latest transaction was disclosed on 5 May 2026 (Acquisition). Among the most active insiders: SR ONE CAPITAL MANAGEMENT, LLC. The full history is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€21m
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Avalyn Pharma Inc. Strong Buy (bullish), based on 4 analysts. Average price target: US$60.00.
52Σ signal
Buys €21mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.